ArticleBMC veterinary research2026
Nuclear factor IC promoting porcine reproductive and respiratory syndrome virus (PRRSV) replication and suppressing type I interferon transcription.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porcine reproductive and respiratory syndrome virus (PRRSV) is the most rapidly mutating RNA virus and causes billions of dollars in annual losses for the global pig industry, making it a persistent threat to swine health. Identifying and targeting host proteins involved in PRRSV replication could provide novel and conserved targets for anti-PRRSV drug development. The NFI family proteins (NFIA, NFIB, NFIC, and NFIX) are known regulators of DNA virus and retrovirus replication. Given that our previous work identified NFIA and NFIB as inhibitors of PRRSV, this study aimed to determine whether NFIC also modulated PRRSV replication. Firstly, ectopic expression of NFIC significantly enhanced PRRSV replication, while siRNA-mediated knockdown of NFIC resulted in a marked reduction in viral titers in MARC-145 cells. Furthermore, PRRSV infection upregulated NFIC expression, suggesting a coordinated mechanism by which the virus hijacked host factors for its replication. Mechanistically, we demonstrated that NFIC disrupted type I interferon (IFN-I) transcription by blocking the nuclear translocation of phosphorylated interferon regulatory factor 3 (pIRF3), an essential transcription factor for IFN-I induction. In conclusion, PRRSV infection upregulated NFIC expression, which in turn facilitated PRRSV replication and suppressed IFN-I transcription. Given that PRRSV suppressed IFN-I transcription and recombinant IFN-I could clear PRRSV, NFIC could be as a potential target for anti-PRRSV drug development in future studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.